glucose, (beta-d)-isomer has been researched along with Mycoses in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (11.11) | 29.6817 |
2010's | 12 (66.67) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Qian, W; Qiao, S; Shen, S; Wang, T; Xu, Z; Yan, W; Zhu, Y | 1 |
Carreras, E; Català, C; Lozano, F; Orta-Mascaró, M; Simões, IT; Velasco de Andrés, M; Zaragoza, O | 1 |
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Harikrishnan, R; Kumaresan, V; Palanisamy, R | 1 |
Anzawa, K; Mochizuki, T; Nagai, Y; Nakamura, T; Nishibu, A; Ogawa, K; Takatsu, K; Watanabe, Y; Yasoshima, M; Yoshida, N | 1 |
Alonso, S; Castrillo, A; de la Rosa, JV; Fernández, N; Márquez, S; Rodríguez, M; Sánchez Crespo, M | 1 |
Aliprantis, A; Glimcher, LH; Greenblatt, MB; Hu, B | 1 |
Nyaundi, T; Rajagopalan, R; Rawal, N; Salvi, VP | 1 |
Heinrich, V; Herant, M; Lee, CY | 1 |
MACKIEWICZ, I; RUDZKI, E; RZUCIDLO, L; SOBOLEWSKA, S; STACHOW, A | 1 |
Huang, Y; Keshvara, L; Keshwara, R; Ozment-Skelton, T; Shah, VB; Williams, DL | 1 |
Corbel, MJ; Eades, SM | 1 |
Agarwal, D; Assmus, M; Krambeck, A; Large, T; Lee, M; Woloshuk, A | 1 |
Adamson, KA; Bain, SC; Barnes, DJ; Chowdhury, TA; Chuah, LL; Morris, DS; Robinson, AM; Ryder, REJ; Thong, KY; Yadagiri, M | 1 |
Aibe, M; Horikawa, M; Inai, M; Kaku, H; Shimazu, M; Tsunoda, T | 1 |
Capuano, G; Fung, A; Mayer, C; Nyirjesy, P; Sobel, JD; Usiskin, K; Ways, K | 1 |
Alba, M; Capuano, G; de Zeeuw, D; Desai, M; Fulcher, G; Jiang, J; Mahaffey, KW; Matthews, D; Meininger, G; Neal, B; Perkovic, V; Shaw, W; Vercruysse, F; Ways, K | 1 |
Bode, B; Fung, A; Harris, S; Meininger, G; Stenlöf, K; Sullivan, D; Usiskin, K | 1 |
An, Q; Hückelhoven, R; Kogel, KH; van Bel, AJ | 1 |
3 trial(s) available for glucose, (beta-d)-isomer and Mycoses
Article | Year |
---|---|
Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies.
Topics: Aged; Canagliflozin; Diabetes Mellitus, Type 2; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Mycoses; Thiophenes | 2014 |
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.
Topics: Blood Glucose; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Glycosuria; Humans; Hypoglycemia; Hypoglycemic Agents; Hypovolemia; Insulin; Male; Middle Aged; Mycoses; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Urinary Tract Infections; Weight Loss | 2015 |
Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diuresis; Double-Blind Method; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Mycoses; Osmolar Concentration; Thiophenes; Urinary Tract Infections | 2015 |
15 other study(ies) available for glucose, (beta-d)-isomer and Mycoses
Article | Year |
---|---|
Card9 protects fungal peritonitis through regulating Malt1-mediated activation of autophagy in macrophage.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autophagy; CARD Signaling Adaptor Proteins; Macrophages; Mice; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Mycoses; Peritonitis; Zymosan | 2022 |
Discordant susceptibility of inbred C57BL/6 versus outbred CD1 mice to experimental fungal sepsis.
Topics: Animals; Animals, Outbred Strains; Bacterial Outer Membrane Proteins; Candida albicans; Candidiasis; CD5 Antigens; Cytokines; Disease Models, Animal; Disease Susceptibility; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mycoses; Sepsis; Species Specificity; Spleen; Teichoic Acids; Zymosan | 2019 |
Functional roles and gene regulation of tumor necrosis factor receptor 1 in freshwater striped murrel.
Topics: Aeromonas hydrophila; Amino Acid Sequence; Animals; Base Sequence; Fish Diseases; Fish Proteins; Fishes; Gene Expression Regulation; Gram-Negative Bacterial Infections; Immunity, Innate; Kidney; Molecular Sequence Data; Molecular Weight; Mycoses; Open Reading Frames; Phagocytes; Protein Structure, Tertiary; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Sequence Alignment; Tetradecanoylphorbol Acetate; Zymosan | 2015 |
Glycyrrhetinic acid inhibits contact hypersensitivity induced by trichophytin via dectin-1.
Topics: Animals; Anti-Inflammatory Agents; Cell Survival; Chemokine CXCL2; Cytokines; Dermatitis, Contact; Enzyme-Linked Immunosorbent Assay; Glycyrrhetinic Acid; Glycyrrhiza; Inflammation; Interferon-gamma; Interleukin-6; Keratinocytes; Lectins, C-Type; Macrophages; Male; Mice; Mycoses; NF-KappaB Inhibitor alpha; Phosphorylation; Syk Kinase; Trichophytin; Trichophyton; Tumor Necrosis Factor-alpha; Zymosan | 2016 |
Fungal pattern receptors down-regulate the inflammatory response by a cross-inhibitory mechanism independent of interleukin-10 production.
Topics: Animals; Cells, Cultured; Dendritic Cells; Humans; Inflammation; Interferon Regulatory Factor-3; Interferon Type I; Interleukin-10; Mice; Mice, Inbred C57BL; Mice, Knockout; Mycoses; Phosphorylation; Receptor, Interferon alpha-beta; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Zymosan | 2017 |
Calcineurin regulates innate antifungal immunity in neutrophils.
Topics: Animals; Antifungal Agents; beta-Glucans; Calcineurin; Candida albicans; Candidiasis; Cyclosporine; Disease Susceptibility; Homeostasis; Humans; Immunity, Innate; Immunosuppressive Agents; Mice; Mycoses; Neutrophils; Polysaccharides, Bacterial; Zymosan | 2010 |
Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.
Topics: Adsorption; Alleles; Cell Line, Tumor; Complement C1q; Complement Pathway, Classical; Complement Pathway, Mannose-Binding Lectin; Flow Cytometry; Humans; Mannose-Binding Lectin; Monocytes; Mycoses; Opsonin Proteins; Phagocytosis; Point Mutation; Recombinant Proteins; Risk; Saccharomyces cerevisiae; Zymosan | 2010 |
Target-specific mechanics of phagocytosis: protrusive neutrophil response to zymosan differs from the uptake of antibody-tagged pathogens.
Topics: Actins; Antibodies; Biomechanical Phenomena; Cell Movement; Cells, Cultured; Fungi; Humans; Models, Biological; Mycoses; Myosin Type II; Neutrophils; Phagocytosis; Zymosan | 2011 |
[Research on the increase in pathogenicity for mice of Salmonella typhi and Staphylococcus aureus under the influence of yeastlike fungi or yeast zymosan].
Topics: Animals; Fungi; Mice; Micrococcus; Mycoses; Polysaccharides; Salmonella typhi; Staphylococcal Infections; Staphylococcus aureus; Virulence; Yeasts; Zymosan | 1957 |
Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner.
Topics: Animals; beta-Glucans; Cell Membrane; Cells, Cultured; Chemokines; Cytokines; Intracellular Signaling Peptides and Proteins; Lectins, C-Type; Membrane Proteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Microglia; Mycoses; Nerve Tissue Proteins; Phagocytosis; Phosphorylation; Protein-Tyrosine Kinases; Reactive Oxygen Species; Signal Transduction; Solubility; Syk Kinase; Toll-Like Receptor 2; Zymosan | 2008 |
Factors determining the susceptibility of mice to experimental phycomycosis.
Topics: Age Factors; Animals; Azathioprine; Brain; Cortisone; Cyclophosphamide; Disease Models, Animal; Female; Ferrous Compounds; Fungi; gamma-Globulins; Immune Sera; Immunity; Kidney; Male; Mice; Mice, Inbred C3H; Mycoses; Sex Factors; Species Specificity; Zymosan | 1975 |
A case of ureteral fungal mass removal in a patient taking empagliflozin.
Topics: Aged; Benzhydryl Compounds; Candida glabrata; Female; Glucosides; Humans; Mycoses; Pyelitis; Sodium-Glucose Transporter 2 Inhibitors; Ureteroscopy | 2021 |
Clinical risk factors predicting genital fungal infections with sodium-glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit.
Topics: Aged; Benzhydryl Compounds; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Logistic Models; Male; Medical Audit; Middle Aged; Mycoses; Odds Ratio; Recurrence; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; United Kingdom | 2018 |
A role of uroleuconaphins, polyketide red pigments in aphid, as a chemopreventor in the host defense system against infection with entomopathogenic fungi.
Topics: Animals; Antifungal Agents; Aphids; Ascomycota; Fungi; Glucosides; Hypocreales; Mycoses; Polyketides; Sugars | 2018 |
Multivesicular bodies participate in a cell wall-associated defence response in barley leaves attacked by the pathogenic powdery mildew fungus.
Topics: Ascomycota; Calcium; Cell Wall; Cytoplasmic Vesicles; Endocytosis; Exocytosis; Glucans; Hordeum; Hydrogen Peroxide; Immunity, Innate; Immunohistochemistry; Microscopy, Electron, Transmission; Mycoses; Peroxidase; Plant Diseases; Plant Leaves | 2006 |